Category: Issue Alert

New AHIP Issue Brief: Cost-sharing options meet patients’ health and financial needs

A new issue brief from AHIP outlines one of the many ways health plans prevent ever-increasing prescription drug prices from making critically important medications out of reach for millions of Americans. Continue reading

Posted in: Issue Alert

Listicle of the Day: Bloomberg on the Factors Driving Premiums

Bloomberg News has produced a handy list of factors to understand when looking at changes in health care premiums. Continue reading

Posted in: Issue Alert

When Providers Merge, Consumers Pay

When hospital and physician practices merge, consumers often pay the price. Continue reading

Posted in: Health Care Costs, Issue Alert

Health Plans Leading the Way on Affordability

We all want more affordable health coverage, but to achieve it, every sector of the health care industry must do its part – including health plans. Continue reading

Posted in: Health Care Costs, Issue Alert

The Hepatitis C Health and Pricing Crisis

Yesterday, the Centers for Medicare & Medicaid Services (CMS) announced that it will cover hepatitis C screenings for Medicare beneficiaries who are at high risk of being infected or meet other criteria. Continue reading

Posted in: Health Care Costs, Issue Alert

Hospital Prices: Anyone’s Guess

We’re reminded again this week that the price for treatments at hospitals across the country can be best summed up in two words: anyone’s guess. Continue reading

Posted in: Health Care Costs, Issue Alert

Ignagni: Changing the Game to Deliver a 21st Century Health System for Patients

This morning at the 2014 Health Datapalooza, AHIP President and CEO Karen Ignagni delivered remarks on the ways health plans are using data to fundamentally change the game, putting patients in the driver’s seat of decision making. Continue reading

Posted in: Issue Alert, Must See TV

“Is the Hallmark of Rx Innovation Higher Prices?”

In nearly all sectors of the economy, innovation not only provides advancement, but also lowers costs for consumers. Unfortunately, drug companies seem to believe pharmaceutical innovation simply allows them to price their products higher and higher. Continue reading

Posted in: Health Care Costs, Issue Alert

Chart of the Day: California’s Projected Spending on Sovaldi vs. Spending on Education

“California, for example, might have to spend more on buying Sovaldi for its Medicaid beneficiaries than it currently does on all K-12 and higher education.” Continue reading

Posted in: Cost Alert, Health Care Costs, Issue Alert

“Lightning Rod” Drug Sparks “Fierce Debate” Over Rx Prices

In health care circles these days, you can’t turn around without hearing about the high cost of specialty pharmaceuticals – in particular the latest hepatitis C drug, Sovaldi. As Vox noted, “the fiercest debate in health care is about a $1,000 pill.” Continue reading

Posted in: Cost Alert, Health Care Costs, Issue Alert